Table 2.
HIV-1 Drug Resistance Mutations by Patient Group
| WHO surveillance drug resistance mutation detected | |||||
|---|---|---|---|---|---|
| Sample group | Number of samples (%) | Number of WHO SDRM (%) | NRTI | NNRTI | PI |
| ARV naive primigravid ≤25 years | 18 (52.9) | 0 (0) | 0 | 0 | 0 |
| ARV naive primigravid 26–30 years | 11 (32.4) | 1 (2.9) | M41L | G190A | 0 |
| Recent infection detected by BED and multiassays | 5 (14.7) | 0 (0) | 0 | 0 | 0 |
| Total | 34 (100) | 1 (2.9) | 1 | 1 | 0 |
SDRM, surveillance drug resistance mutation; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, nonnucleoside reverse transcriptase inhibitor; PI, protease inhibitor; ARV, antiretroviral.